A young woman’s menstrual cycle brought tears to her eyes. But unlike most period-related tears, hers were bright-red tears of blood. When the 25-year-old visited an emergency room with bloody tears oozing from both eyes, it was her second such…
Read More
Suicide risk prediction models could be cost-effective in clinical practice
There are several effective interventions to reduce the risk of suicide, the tenth-leading cause of death in the United States, but difficulties in identifying people at risk for suicide and concerns about the potentially high costs of suicide-prevention strategies have…
Read More
Medical oncologists split on telehealth's clinical effectiveness
A study published this week in the Journal of the American Medical Association Network Open found that although medical oncologists recognized the convenience and access to care presented by telehealth video visits, many raised doubts about its clinical effectiveness. The qualitative…
Read More
Sharpening clinical imaging with AI and currently approved contrast dyes
A new method for analyzing deep-tissue medical images utilizes artificial neural networks to decrease background noise, giving medical practitioners a clearer, sharper image of deep tissues than currently available. Near-infrared (NIR) fluorescence imaging is a tool used to visualize vascular structures…
Read More
Telehealth poses big cybersecurity dangers, Harvard researchers warn
A Harvard Medical School team published a letter in the Journal of the American Medical Informatics Association this week warning of the “substantial” information security concerns around telehealth. The authors, led by organizational cybersecurity researcher Mohammad S. Jalali, note that…
Read More
Few clinical studies examine high blood pressure treatments for Black Americans
High blood pressure affects Black adults in the U.S. more than any other group. But studies exploring its impact on them remain scant, an analysis of clinical trials over the past decade shows. The analysis, published Monday in the Journal…
Read More
Immune modulator drugs for COVID-19 focus of major NIH clinical trial
One of the most vexing aspects of the COVID-19 pandemic is the novel coronavirus’s ability to turn the body’s immune system against the body. After the virus has been cleared from the body, the immune system sometimes continues to hurtle…
Read More
How virtual care can keep pregnant patients safer from COVID-19
This past week, the U.S. Centers for Disease Control and Prevention released a trove of data suggesting that pregnant patients might be at increased risk for severe illness associated with COVID-19. In light of the statistics, CDC advised that measures…
Read More
Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)
WEST CHESTER, Pa., November 10, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced positive topline results from its Phase 2 CARE-1 clinical study of…
Read More
Investigational ALS drug prolongs patient survival in clinical trial
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial…
Read More